CSF2 and neoplasm: Meanwhile, GM-CSF triggers the differentiation of Flt3+ monocytes to inflammatory monocyte-derived dendritic cells (moDCs), which exercise potent anti-tumor activities through reactive oxygen species (ROS)-dependent mechanisms, as well as by priming T cells through PPARγ-dependent pathways [24–26].